PURPOSE: To determine the incidence of new chorioretinal lesions in children with toxoplasmosis diagnosed after, and therefore not treated during, their first year. DESIGN: Prospective longitudinal cohort study. METHODS: Thirty-eight children were evaluated in Chicago between 1981 and 2005 for new chorioretinal lesions. Thirty-eight children and mothers had serum IgG antibody to Toxoplasma gondii. RESULTS: Twenty-eight of 38 children had one of the following: diagnosis with serum antibody to T. gondii indicative of chronic infection at age 24 months, central nervous system calcifications, hydrocephalus, illness compatible with congenital toxoplasmosis perinatally but not diagnosed at that time. Twenty-five returned for follow-up during 1981 to 2005. Their mean (range) age at last exam was 10.9 +/- 5.7 (range, 3.5 to 27.2) years and mean follow-up was 5.7 +/- 2.9 years. Eighteen (72%) children developed at least one new lesion. Thirteen (52%) had new central lesions, 11 (44%) had new peripheral lesions, and six (24%) had both. Thirteen (52%) had new lesions diagnosed at age > or =10 years. New lesions were found at more than one visit in four (22%), and bilateral new lesions developed in seven (39%) of 18 children who developed new lesions. Of 10 additional children with eye findings and serologic tests indicative of chronic infection, six returned for follow-up, four (67%) developing new lesions at > or =10 years of age. CONCLUSIONS: More than 70% developed new chorioretinal lesions. New lesions were commonly diagnosed after the first decade of life.
PURPOSE: To determine the incidence of new chorioretinal lesions in children with toxoplasmosis diagnosed after, and therefore not treated during, their first year. DESIGN: Prospective longitudinal cohort study. METHODS: Thirty-eight children were evaluated in Chicago between 1981 and 2005 for new chorioretinal lesions. Thirty-eight children and mothers had serum IgG antibody to Toxoplasma gondii. RESULTS: Twenty-eight of 38 children had one of the following: diagnosis with serum antibody to T. gondii indicative of chronic infection at age 24 months, central nervous system calcifications, hydrocephalus, illness compatible with congenital toxoplasmosis perinatally but not diagnosed at that time. Twenty-five returned for follow-up during 1981 to 2005. Their mean (range) age at last exam was 10.9 +/- 5.7 (range, 3.5 to 27.2) years and mean follow-up was 5.7 +/- 2.9 years. Eighteen (72%) children developed at least one new lesion. Thirteen (52%) had new central lesions, 11 (44%) had new peripheral lesions, and six (24%) had both. Thirteen (52%) had new lesions diagnosed at age > or =10 years. New lesions were found at more than one visit in four (22%), and bilateral new lesions developed in seven (39%) of 18 children who developed new lesions. Of 10 additional children with eye findings and serologic tests indicative of chronic infection, six returned for follow-up, four (67%) developing new lesions at > or =10 years of age. CONCLUSIONS: More than 70% developed new chorioretinal lesions. New lesions were commonly diagnosed after the first decade of life.
Authors: Laura Phan; Kristen Kasza; Jessica Jalbrzikowski; A Gwendolyn Noble; Paul Latkany; Annie Kuo; William Mieler; Sanford Meyers; Peter Rabiah; Ken Boyer; Charles Swisher; Marilyn Mets; Nancy Roizen; Simone Cezar; Jack Remington; Paul Meier; Rima McLeod Journal: Ophthalmology Date: 2007-09-06 Impact factor: 12.079
Authors: Claudio Silveira; Rubens Belfort; Cristina Muccioli; Gary N Holland; Cesar G Victora; Bernardo L Horta; Fei Yu; Robert B Nussenblatt Journal: Am J Ophthalmol Date: 2002-07 Impact factor: 5.258
Authors: J McAuley; K M Boyer; D Patel; M Mets; C Swisher; N Roizen; C Wolters; L Stein; M Stein; W Schey Journal: Clin Infect Dis Date: 1994-01 Impact factor: 9.079
Authors: M B Mets; E Holfels; K M Boyer; C N Swisher; N Roizen; L Stein; M Stein; J Hopkins; S Withers; D Mack; R Luciano; D Patel; J S Remington; P Meier; R McLeod Journal: Am J Ophthalmol Date: 1996-09 Impact factor: 5.258
Authors: C Binquet; M Wallon; C Quantin; L Kodjikian; J Garweg; J Fleury; F Peyron; M Abrahamowicz Journal: Epidemiol Infect Date: 2003-12 Impact factor: 2.451
Authors: N Roizen; C N Swisher; M A Stein; J Hopkins; K M Boyer; E Holfels; M B Mets; L Stein; D Patel; P Meier Journal: Pediatrics Date: 1995-01 Impact factor: 7.124
Authors: Samantha R Béla; Míriam S Dutra; Ernest Mui; Alexandre Montpetit; Fernanda S Oliveira; Sérgio C Oliveira; Rosa M E Arantes; Lis R Antonelli; Rima McLeod; Ricardo T Gazzinelli Journal: Infect Immun Date: 2012-10-01 Impact factor: 3.441
Authors: Kenneth Boyer; Dolores Hill; Ernest Mui; Kristen Wroblewski; Theodore Karrison; J P Dubey; Mari Sautter; A Gwendolyn Noble; Shawn Withers; Charles Swisher; Peter Heydemann; Tiffany Hosten; Jane Babiarz; Daniel Lee; Paul Meier; Rima McLeod Journal: Clin Infect Dis Date: 2011-10-21 Impact factor: 9.079
Authors: Rima McLeod; Kenneth M Boyer; Daniel Lee; Ernest Mui; Kristen Wroblewski; Theodore Karrison; A Gwendolyn Noble; Shawn Withers; Charles N Swisher; Peter T Heydemann; Mari Sautter; Jane Babiarz; Peter Rabiah; Paul Meier; Michael E Grigg Journal: Clin Infect Dis Date: 2012-04-11 Impact factor: 9.079
Authors: Hua Cong; Ernest J Mui; William H Witola; John Sidney; Jeff Alexander; Alessandro Sette; Ajesh Maewal; Rima McLeod Journal: Immunome Res Date: 2010-12-03
Authors: Despina Contopoulos-Ioannidis; Kelsey M Wheeler; Raymund Ramirez; Cindy Press; Ernest Mui; Ying Zhou; Christine Van Tubbergen; Sheela Prasad; Yvonne Maldonado; Shawn Withers; Kenneth M Boyer; A Gwendolyn Noble; Peter Rabiah; Charles N Swisher; Peter Heydemann; Kristen Wroblewski; Theodore Karrison; Michael E Grigg; Jose G Montoya; Rima McLeod Journal: Clin Infect Dis Date: 2015-09-24 Impact factor: 9.079